STOCK TITAN

Inogen Inc Stock Price, News & Analysis

INGN Nasdaq

Welcome to our dedicated page for Inogen news (Ticker: INGN), a resource for investors and traders seeking the latest updates and insights on Inogen stock.

News for Inogen Inc (INGN) centers on its activities as a medical technology company focused on respiratory products for homecare use. This page aggregates company press releases, earnings announcements, product launches, and other public updates that Inogen provides to investors, patients, and partners.

Inogen regularly issues quarterly financial results and outlook updates, detailing revenue by sales and rental categories, business-to-business and direct-to-consumer performance, gross margin trends, operating expenses, and non-GAAP measures such as EBITDA and adjusted EBITDA. These releases often highlight factors driving performance, such as demand from domestic and international business-to-business customers and changes in direct-to-consumer and rental revenue.

Product-related news is another key theme. Recent announcements include the launch of the Voxi 5 stationary oxygen concentrator, designed to expand access to oxygen therapy for long-term care patients in the United States, and the introduction of Aurora CPAP masks for patients with obstructive sleep apnea. Such updates illustrate how Inogen is broadening its respiratory care portfolio beyond portable oxygen concentrators into stationary oxygen therapy and sleep-therapy accessories.

Corporate and leadership developments, such as technology and executive appointments, also appear in Inogen’s news flow, offering context on how the company is organizing around digital health, connected devices, and operational execution. Investors and observers can use this news page to follow Inogen’s financial trajectory, portfolio evolution, and strategic priorities in home respiratory and sleep care.

For anyone tracking INGN stock, revisiting this page provides a consolidated view of Inogen’s latest earnings releases, conference call announcements, and product milestones, all drawn from the company’s own public communications.

Rhea-AI Summary

Inogen, a medical technology company specializing in respiratory products, will announce its third quarter 2020 financial results on November 4, 2020, after market close. The company will host a conference call at 1:30 PM PT/4:30 PM ET for investors and analysts to discuss the results. Interested participants can join by calling the provided numbers or by accessing the live webcast through Inogen's Investor Relations website. A replay of the call will be available until November 18, 2020. For more information, visit the Inogen website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags

FAQ

What is the current stock price of Inogen (INGN)?

The current stock price of Inogen (INGN) is $6.06 as of March 13, 2026.

What is the market cap of Inogen (INGN)?

The market cap of Inogen (INGN) is approximately 166.1M.

INGN Rankings

INGN Stock Data

166.12M
23.87M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
BEVERLY

INGN RSS Feed